BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salerno F, Cazzaniga M, Merli M, Spinzi G, Saibeni S, Salmi A, Fagiuoli S, Spadaccini A, Trotta E, Laffi G, Koch M, Riggio O, Boccia S, Felder M, Balzani S, Bruno S, Angeli P;  Italian Association of the Hospital Gastroenterologists (AIGO) investigators. Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice. J Hepatol. 2011;55:1241-1248. [PMID: 21703199 DOI: 10.1016/j.jhep.2011.03.012] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Wong F, Angeli P. New diagnostic criteria and management of acute kidney injury. J Hepatol. 2017;66:860-861. [PMID: 27984175 DOI: 10.1016/j.jhep.2016.10.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
2 Liu C, Huang C, Tsai H, Su Y, Huang S, Lee K, Hsieh Y, Li T, Tsai C, Chong L, Ou S, Yang Y, Fan W, Hou M, Lin H, Lee S. Serum adrenomedullin and urinary thromboxane B 2 help early categorizing of acute kidney injury in decompensated cirrhotic patients: A prospective cohort study. Hepatol Res 2018;48. [DOI: 10.1111/hepr.12917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Caraceni P, Angeli P, Prati D, Bernardi M, Liumbruno GM, Bennardello F, Piccoli P, Velati C; Italian Association for the Study of the Liver (AISF)., Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis. Blood Transfus 2016;14:8-22. [PMID: 26820615 DOI: 10.2450/2016.0294-15] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Ginès P, Solà E, Angeli P, Wong F, Nadim MK, Kamath PS. Hepatorenal syndrome. Nat Rev Dis Primers 2018;4:23. [PMID: 30213943 DOI: 10.1038/s41572-018-0022-7] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 18.7] [Reference Citation Analysis]
5 Zheng JN, Han YJ, Zou TT, Zhou YJ, Sun DQ, Zhong JH, Braddock M, Zheng MH. Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysis. Expert Rev Gastroenterol Hepatol 2017;11:1009-18. [PMID: 28708431 DOI: 10.1080/17474124.2017.1356223] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
6 Varajic B, Cavallazzi R, Mann J, Furmanek S, Guardiola J, Saad M. High versus low mean arterial pressures in hepatorenal syndrome: A randomized controlled pilot trial. J Crit Care 2019;52:186-92. [PMID: 31096099 DOI: 10.1016/j.jcrc.2019.04.006] [Reference Citation Analysis]
7 Colle I, Laterre PF. Hepatorenal syndrome: the clinical impact of vasoactive therapy. Expert Rev Gastroenterol Hepatol. 2018;12:173-188. [PMID: 29258378 DOI: 10.1080/17474124.2018.1417034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
8 Salerno F, Navickis RJ, Wilkes MM. Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis. BMC Gastroenterol 2015;15:167. [PMID: 26606982 DOI: 10.1186/s12876-015-0389-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
9 Huggins JT, Doelken P, Walters C, Rockey DC. Point-of-Care Echocardiography Improves Assessment of Volume Status in Cirrhosis and Hepatorenal Syndrome. Am J Med Sci. 2016;351:550-553. [PMID: 27140719 DOI: 10.1016/j.amjms.2016.02.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
10 Jiang W, Hu Y, Sun Y, Shen Y, Xun Y. Prevalence and short‐term outcome of acute kidney injury in patients with acute‐on‐chronic liver failure: A meta‐analysis. J Viral Hepat 2020;27:810-7. [DOI: 10.1111/jvh.13287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Licata A, Maida M, Bonaccorso A, Macaluso FS, Cappello M, Craxì A, Almasio PL. Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study. World J Hepatol 2013; 5(12): 685-691 [PMID: 24432185 DOI: 10.4254/wjh.v5.i12.685] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
12 Thongprayoon C, Kaewput W, Petnak T, O'Corragain OA, Boonpheng B, Bathini T, Vallabhajosyula S, Pattharanitima P, Lertjitbanjong P, Qureshi F, Cheungpasitporn W. Impact of Palliative Care Services on Treatment and Resource Utilization for Hepatorenal Syndrome in the United States. Medicines (Basel) 2021;8:21. [PMID: 34065828 DOI: 10.3390/medicines8050021] [Reference Citation Analysis]
13 Zhang Y, Xiang B, Wu Y, Xie X, Wang J, Jin S. Risk factors and associated outcomes of early acute kidney injury in pediatric liver transplant recipients: A retrospective study. J Pediatr Surg 2020;55:446-50. [PMID: 31466815 DOI: 10.1016/j.jpedsurg.2019.07.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wong F. The evolving concept of acute kidney injury in patients with cirrhosis. Nat Rev Gastroenterol Hepatol. 2015;12:711-719. [PMID: 26484442 DOI: 10.1038/nrgastro.2015.174] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
15 Nevens F, Bittencourt PL, Coenraad MJ, Ding H, Hou MC, Laterre PF, Mendizabal M, Ortiz-Olvera NX, Vorobioff JD, Zhang W, Angeli P. Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis. Dig Dis Sci 2019;64:1419-31. [PMID: 30684079 DOI: 10.1007/s10620-018-5448-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Rajakumar A, Appuswamy E, Kaliamoorthy I, Rela M. Renal Dysfunction in Cirrhosis: Critical Care Management. Indian J Crit Care Med 2021;25:207-14. [PMID: 33707901 DOI: 10.5005/jp-journals-10071-23721] [Reference Citation Analysis]
17 Turk T, Al Saadi T, Sawaf B, Alkhatib M, Zakaria MI, Daaboul B. Progressive liver failure post acute hepatitis A, over a three-month period, resulting in hepatorenal syndrome and death. Gastroenterol Rep (Oxf) 2017;5:161-4. [PMID: 27247182 DOI: 10.1093/gastro/gow009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
18 Rodriguez E, Henrique Pereira G, Solà E, Elia C, Barreto R, Pose E, Colmenero J, Fernandez J, Navasa M, Arroyo V. Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes. Liver Transpl. 2015;21:1347-1354. [PMID: 26178066 DOI: 10.1002/lt.24210] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
19 Rey R M, Delgado AF, De Zubiria A, Pinto R, De la Hoz-Valle JA, Pérez-Riveros ED, Ardila G, Sierra-Arango F. Prevalence and short-term outcome of hepatorenal syndrome: A 9-year experience in a high-complexity hospital in Colombia. PLoS One 2020;15:e0239834. [PMID: 33079947 DOI: 10.1371/journal.pone.0239834] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 O'leary JG, Orloff SL, Levitsky J, Martin P, Foley DP. Keeping high model for end-stage liver disease score liver transplantation candidates alive: KEEPING LT CANDIDATES ALIVE. Liver Transpl 2015;21:1428-37. [DOI: 10.1002/lt.24329] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
21 Sohn W, Kim JH, Cho J. Effect of acute kidney injury on long‐term outcomes of spontaneous bacterial peritonitis in cirrhotic patients using the International Club of Ascites‐acute kidney injury criteria. Journal of Gastroenterology and Hepatology 2020;35:870-6. [DOI: 10.1111/jgh.14871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Premkumar M, Rangegowda D, Kajal K, Khumuckham JS. Noninvasive estimation of intravascular volume status in cirrhosis by dynamic size and collapsibility indices of the inferior vena cava using bedside echocardiography. JGH Open 2019;3:322-8. [PMID: 31406926 DOI: 10.1002/jgh3.12166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Belcher JM, Coca SG, Parikh CR. Creatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-Analysis. PLoS One 2015;10:e0135625. [PMID: 26295585 DOI: 10.1371/journal.pone.0135625] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bucsics T, Schwabl P, Mandorfer M, Bota S, Sieghart W, Ferlitsch A, Trauner M, Reiberger T, Peck-Radosavljevic M. The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascites. Liver Int 2016;36:1649-56. [PMID: 27169985 DOI: 10.1111/liv.13160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
25 Low G, Alexander GJ, Lomas DJ. Hepatorenal syndrome: aetiology, diagnosis, and treatment. Gastroenterol Res Pract 2015;2015:207012. [PMID: 25649410 DOI: 10.1155/2015/207012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
26 Velez JCQ, Therapondos G, Juncos LA. Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.Nat Rev Nephrol. 2020;16:137-155. [PMID: 31723234 DOI: 10.1038/s41581-019-0218-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
27 Arab JP, Claro JC, Arancibia JP, Contreras J, Gómez F, Muñoz C, Nazal L, Roessler E, Wolff R, Arrese M, Benítez C. Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus. World J Hepatol 2016; 8(25): 1075-1086 [PMID: 27660674 DOI: 10.4254/wjh.v8.i25.1075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Marinho RT, Duarte H, Gíria J, Nunes J, Ferreira A, Velosa J. The burden of alcoholism in fifteen years of cirrhosis hospital admissions in Portugal. Liver Int 2015;35:746-55. [PMID: 24750642 DOI: 10.1111/liv.12569] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
29 Nassar Junior AP, Farias AQ, D' Albuquerque LA, Carrilho FJ, Malbouisson LM. Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis. PLoS One 2014;9:e107466. [PMID: 25203311 DOI: 10.1371/journal.pone.0107466] [Cited by in Crossref: 84] [Cited by in F6Publishing: 62] [Article Influence: 12.0] [Reference Citation Analysis]
30 Wong F. Acute kidney injury in liver cirrhosis: new definition and application. Clin Mol Hepatol. 2016;22:415-422. [PMID: 27987536 DOI: 10.3350/cmh.2016.0056] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
31 Sheng XY, Lin FY, Wu J, Cao HC. Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study. World J Gastroenterol 2021; 27(20): 2615-2629 [PMID: 34092979 DOI: 10.3748/wjg.v27.i20.2615] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 D’amico G, Perricone G. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter? Curr Hepatology Rep 2019;18:144-56. [DOI: 10.1007/s11901-019-00473-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V, Häfner M, Kramer L, Maieron A, Payer B. Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr. 2013;125:200-219. [PMID: 23579878 DOI: 10.1007/s00508-013-0337-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
34 Wong F, O'Leary JG, Reddy KR, Garcia-Tsao G, Fallon MB, Biggins SW, Subramanian RM, Thuluvath PJ, Kamath PS, Patton H, Maliakkal B, Tandon P, Vargas H, Thacker L, Bajaj JS. Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes. Am J Gastroenterol 2017;112:1103-10. [PMID: 28440305 DOI: 10.1038/ajg.2017.122] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 9.5] [Reference Citation Analysis]
35 Fukazawa K, Lee HT. Updates on Hepato-Renal Syndrome. J Anesth Clin Res. 2013;4:352. [PMID: 24459604 DOI: 10.4172/2155-6148.1000352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
36 Sanyal AJ, Boyer TD, Frederick RT, Wong F, Rossaro L, Araya V, Vargas HE, Reddy KR, Pappas SC, Teuber P, Escalante S, Jamil K. Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies. Aliment Pharmacol Ther. 2017;45:1390-1402. [PMID: 28370090 DOI: 10.1111/apt.14052] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 9.5] [Reference Citation Analysis]
37 Bass LM, Shneider BL, Henn L, Goodrich NP, Magee JC; Childhood Liver Disease Research Network (ChiLDReN). Clinically Evident Portal Hypertension: An Operational Research Definition for Future Investigations in the Pediatric Population. J Pediatr Gastroenterol Nutr 2019;68:763-7. [PMID: 30908382 DOI: 10.1097/MPG.0000000000002333] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 13.0] [Reference Citation Analysis]
38 Bucsics T, Krones E. Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome. Gastroenterol Rep (Oxf). 2017;5:127-137. [PMID: 28533910 DOI: 10.1093/gastro/gox009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
39 Wong F. Recent advances in our understanding of hepatorenal syndrome. Nat Rev Gastroenterol Hepatol 2012;9:382-91. [DOI: 10.1038/nrgastro.2012.96] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 7.7] [Reference Citation Analysis]
40 Ginès P, Cárdenas A, Schrier RW. Renal Failure in Cirrhosis. Seldin and Giebisch's The Kidney. Elsevier; 2013. pp. 2633-44. [DOI: 10.1016/b978-0-12-381462-3.00079-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Mindikoglu AL, Pappas SC. New Developments in Hepatorenal Syndrome. Clin Gastroenterol Hepatol 2018;16:162-177.e1. [PMID: 28602971 DOI: 10.1016/j.cgh.2017.05.041] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
42 Fagundes C, Ginès P. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis. Am J Kidney Dis. 2012;59:874-885. [PMID: 22480795 DOI: 10.1053/j.ajkd.2011.12.032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
43 D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68:563-576. [PMID: 29111320 DOI: 10.1016/j.jhep.2017.10.020] [Cited by in Crossref: 116] [Cited by in F6Publishing: 97] [Article Influence: 29.0] [Reference Citation Analysis]
44 Kumar R, Priyadarshi RN, Anand U. Chronic renal dysfunction in cirrhosis: A new frontier in hepatology. World J Gastroenterol 2021; 27(11): 990-1005 [PMID: 33776368 DOI: 10.3748/wjg.v27.i11.990] [Reference Citation Analysis]
45 Zardi EM, Zardi DM, Giorgi C, Chin D, Dobrina A. Portopulmonary hypertension and hepatorenal syndrome. Two faces of the same coin. European Journal of Internal Medicine 2017;43:22-7. [DOI: 10.1016/j.ejim.2017.05.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
46 Italian Association for the Study of the Liver (AISF)., Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis. Dig Liver Dis 2016;48:4-15. [PMID: 26802734 DOI: 10.1016/j.dld.2015.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]